IVF Success Rates | Dr Matthew Holland | Genea Newcastle

Starting your IVF journey is a significant step, and it’s natural to have questions about what to expect and where to begin. Having access to verified outcome data can help you feel more informed as you navigate your options. Dr Matthew Holland, a fertility specialist at Genea Newcastle, supports transparent reporting of IVF outcomes so patients have the information they need.

The figures below are sourced from YourIVFSuccess, an independent government-funded website that publishes verified IVF outcome data for accredited Australian clinics that opt into public reporting.  All Genea clinics participate.

The data spans several reporting periods and measures of treatment success. Across every measure, Genea Newcastle performs above the Australian national average.

Genea Newcastle IVF success
IVF

Why IVF outcomes are reported across multiple measures

IVF is not a single event but a process that spans several stages. From egg collection to embryo transfer and pregnancy, each stage tells a different part of the story when it comes to treatment outcomes.

Because of this, success rates are captured across a number of different measures. The five measures below cover varying reporting periods, offering both historical context and the most recently available data from Genea Newcastle.

IVF success rate measures

Measure 1 - Births per complete egg retrieval (including the later transfer of resulting embryos)

A single egg retrieval cycle can produce several embryos, which may be transferred across multiple months or even years. This measure shows the chance of a live birth from all fresh and frozen embryo transfers resulting from one complete egg retrieval cycle.

Because it accounts for every embryo created from that retrieval, it gives a comprehensive picture of the potential outcome from a single cycle.

Age Group Genea Newcastle National
<35 years 62.0% 46.4%
35-42 years 36.4% 23.6%
Egg retrieval year: 2022 | Embryo transfer years: 2022 & 2023

Measure 2 - Births per first retrieval cycle (including the later transfer of resulting embryos) for women having their first ever egg retrieval

For those beginning IVF for the first time, this measure can be a useful reference point. It shows the chance of a live birth from all fresh and frozen embryo transfers resulting from a patient’s first-ever egg retrieval cycle.

Because it focuses solely on first-time retrievals, it allows for a more consistent comparison across patients who are new to IVF treatment.

Age Group Genea Newcastle National
<35 years 69.4% 52.3%
35-42 years 46.0% 30.6%
Egg retrieval year: 2022 | Embryo transfer years: 2022 & 2023

Measure 3 - Births per treatment attempt

This measure reflects the likelihood of achieving a live birth from each individual treatment cycle where an embryo transfer was attempted.

Compared with Measures 1 and 2, it draws on more recent treatment data.

Age Group Genea Newcastle National
<35 years 49.4% 34.5%
35-38 years 43.2% 28.1%
39-42 years 27.1% 16.7%
Treatment year: 2023

Measure 4 - Births per embryo transfer

This measure looks at the chance of a live birth from each individual embryo transferred, whether fresh or frozen, within a single reporting year.

Age Group Genea Newcastle National
<35 years 51.9% 36.9%
35-38 years 46.4% 31.1%
39-42 years 29.4% 19.3%
Treatment year: 2023

Measure 5 - Clinical pregnancies per treatment

Reaching a clinical pregnancy confirmed by ultrasound is a meaningful milestone during IVF treatment. This measure shows the likelihood of achieving that outcome from each treatment attempt involving an intended embryo transfer.

Of all five measures, it represents the most recently published outcome data.

Age Group Genea Newcastle National
<35 years 53.1% 41.4%
35-38 years 42.3% 35.3%
39-42 years 30.5% 24.8%
Treatment year: 2024

Your journey is unique to you

While IVF success rates can provide helpful context when comparing clinic outcomes, they represent overall averages rather than predicting the outcome of treatment for any individual patient.

A range of factors may influence fertility treatment outcomes, including age, fertility diagnosis, ovarian reserve and general medical history. Because every fertility journey is different, personalised medical advice is important when considering IVF or other treatment options.

Dr Matthew Holland takes a personalised approach to fertility care, carefully reviewing each patient’s medical history and individual circumstances to help guide appropriate treatment decisions.

All statistics sourced from  YourIVFSuccess.

FAQs

What are Dr Matthew Holland’s IVF success rates?

Dr Matthew Holland  practices at Genea Newcastle.  IVF outcomes for Genea clinics are independently reported through YourIVFSuccess, a government-funded website that publishes verified treatment outcomes for accredited Australian IVF clinics that participate in public reporting.

Across all five success measures and reporting periods, Genea Newcastle performs above the Australian national average.

For patients having their first IVF egg retrieval, the live birth rate at Genea Newcastle is:

  • 69.4% for patients under 35 (52.3% nationally)
  • 46% for patients aged 35–42 (30.6% nationally)

A full breakdown of outcomes by measure and age group is shown above.

Age is one of the most significant factors influencing IVF outcomes. Both egg quality and egg quantity tend to decline over time, which can affect the likelihood of a successful pregnancy through IVF.

At Genea Newcastle, the reported live birth rate per first egg retrieval cycle is 69.4% for patients under 35, compared with 46% for patients aged 35–42.

During your consultation, Dr Matthew Holland will discuss how age and other individual factors may influence your personal fertility treatment options and potential outcomes.

Success rates for a first IVF attempt are commonly reported as live births per first egg retrieval cycle (Measure 2). This measure includes all embryo transfers — both fresh and frozen — created from a patient’s first egg collection.

At Genea Newcastle, the reported live birth rate per first retrieval cycle is:

  • 69.4% for patients under 35 (52.3% nationally)
  • 46% for patients aged 35–42 (30.6% nationally)

These results are sourced from YourIVFSuccess data (egg retrieval year 2022, embryo transfer years 2022–2023).

During your consultation, Dr Matthew Holland will also discuss how your age, medical history and other individual factors may influence your treatment options and potential outcomes.

IVF outcomes at Genea Newcastle are reported as being above the Australian national average across the YourIVFSuccess measures and age groups shown on this page.

For example, in 2023 births per treatment attempt (Measure 3) were:

  • 49.4% for patients under 35 at Genea Newcastle
  • 34.5% nationally

When reviewing IVF success rates, it’s important to compare clinics using the same reporting measures.

Results may vary depending on patient demographics, reporting timeframes, and how success is defined or measured. The YourIVFSuccess framework standardises five key measures, helping patients compare clinics using consistent data.

Reviewing all five measures across different age groups can provide a more complete overview of reported clinic outcomes.

In Australia, IVF success rates are published at the clinic level rather than for individual specialists. This means the reported outcomes reflect results achieved across the clinic where treatment takes place.

Dr Matthew Holland practises at Genea Newcastle, and the success rates shown on this page represent the outcomes reported for that clinic.

IVF success can be measured in different ways depending on which stage of treatment is being assessed. For example, outcomes may be reported per egg retrieval cycle, per treatment attempt, or per embryo transfer. Because IVF involves several stages — from egg collection to embryo transfer and pregnancy — no single statistic can fully represent the entire treatment process.

For this reason, YourIVFSuccess publishes several standardised measures to provide a more complete picture of reported clinic outcomes.

If you are beginning IVF, Measure 2 (births per first retrieval cycle) can be particularly relevant because it reflects outcomes for patients undergoing their first egg retrieval. Reviewing several measures together can help provide a broader understanding of how outcomes are reported across different stages of treatment.

Genea has also published a detailed guide explaining how to interpret YourIVFSuccess data and IVF outcome measures. You can read it here.

Published IVF success rates provide a useful overview of clinic outcomes but cannot predict an individual patient’s results.

Your chances of success depend on many factors, including your age, fertility diagnosis, ovarian reserve and overall medical history.

During your consultation, Dr Matthew Holland will review your individual circumstances and discuss how these factors may influence your treatment options and potential outcomes.

You can book a consultation with Dr Matthew Holland online here. If you have any questions before your appointment, please contact the team on 02 4952 4409 and they will be happy to assist.

Dr Matthew Holland

Fertility Specialist, Gynaecologist, Obstetric Care.

Based in New Lambton Heights, Dr Holland welcomes patients and couples from Newcastle, Lake Macquarie, Maitland and surrounding areas.

Couples requiring fertility treatment will undergo their procedures locally at The Lingard Hospital at Merewether through Genea Newcastle.

Address

Newcastle Private Specialist Centre
Suites G5-G6, 26 Lookout Road
​New Lambton Heights NSW 2305

FAX: 02 4965 5270

Opening Hours

Dr Matthew Holland © 2026. All Rights Reserved.

SPECIAL ANNOUNCEMENT

IN SUPPORT OF RUNDIPG

Dr Holland’s rooms will be closed on Friday, 15 August 2025